In this regard BCa is not similar to certain other cancers, such as gastric and lung adenocarcinomas, where frequent MET gene amplification leads to ligand-independent activation and enhanced sensitivity to Met inhibition [5]. The gene discussed is MET; the disease is lung adenocarcinoma.